Opexa Therapeutics
Opexa Therapeutics, Inc. is a publicly traded biotechnology company based in Spring, TX. They specialize in developing personalized immunotherapies using their proprietary T-cell technology to treat major illnesses, including multiple sclerosis (MS) and other autoimmune diseases like neuromyelitis optica (NMO). Their leading therapy candidate, Tcelna, is a personalized T-cell immunotherapy currently in Phase IIb clinical development for the treatment of Secondary Progressive MS.
Opexa Therapeutics' mission is to lead the field of Precision Immunotherapy by aligning the interests of patients, employees, and shareholders. They are dedicated to advancing the development of innovative therapies that have the potential to significantly improve the lives of individuals suffering from autoimmune diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.